Some stocks sizzle, then fizzle. Others, though, build long-lasting momentum thanks to strong underlying business ...

Eli Lilly (LLY 0.86%) and Novo Nordisk (NVO -1.53%) have competed for decades. They're both leaders in the areas of insulin ...

Hundreds of vials of black-market weight loss drugs have been seized from a home and two clinics in West Tennessee.

It's been a good year for the stock market as a whole and a tremendous year for a couple of drugmaker start-ups. Shares of ...

Fact checked by Nick Blackmer Eli Lilly’s Zepbound bested Novo Nordisk’s Wegovy in the first head-to-head trial comparing ...

The most common adverse events reported with both treatments were mild to moderate gastrointestinal-related side effects.

A Medina woman was arrested for allegedly selling black market weight loss drugs to local clinics and other individuals in ...

Data continue to show that tirzepatide, called Mounjaro for type 2 diabetes and Zepbound for weight loss, is safe and effective, but side effects remain.

Patients lost an average of 20.2% of their weight with tirzepatide over 72 weeks versus 13.7% with semaglutide.

US: Sharing the topline results from the SURMOUNT-5 phase 3b open-label randomized clinical trial, Eli Lilly and Company ...

Tirzepatide has been shown in clinical trials to be more effective than diet and exercise support alone, and when compared ...

Obesity is one of the greatest public health issues facing the NHS and weight loss drugs, such as tirzepatide, are an important tool in helping people lose weight while also reducing the risk of other ...